Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford's COVID-19 research receives government funding

The three projects include work on an effective vaccine, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.

Another project will examine how existing treatments could be repurposed to treat coronavirus: Professor Sarah Gilbert, £2.2 million for vaccine development and trials; Professor Peter Horby - £2.1 million for research into the effectiveness of current drugs on COVID-19 and Dr Sandy Douglas – £0.4 million, research into vaccine manufacturing capabilities.

The full article is available from the University of Oxford's Website

Similar stories

Oxford University and Brazil Ministry of Health Sign Letter of Intent to Strengthen Cancer Care Across Brazil

The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Dr. Yi-Ling Chen (COI) awarded prestigious ERC Starting Grant

Nigeria rolls out new Oxford R21 malaria vaccine

Developing the first cancer prevention vaccine for Lynch syndrome